Literature DB >> 8865828

A prospective study evaluating the usefulness of continuous supplemental oxygen in various endoscopic procedures.

R Reshef1, M Shiller, R Kinberg, H Rennert, G Rennert, M Herskovits, N Loberant.   

Abstract

The influence of oxygen supplementation on the prevalence of hypoxemia during endoscopic procedures was studied in 289 patients in a prospective clinical trial. The frequency of oxygen desaturation was found to decrease significantly in patients receiving oxygen via nasal prongs, compared to patients not receiving oxygen supplementation. The effect was demonstrated especially in patients who underwent an additional procedure during their endoscopic examinations. Similar effects were found in patients undergoing gastroscopy, colonoscopy, and endoscopic retrograde cholangiopancreatography. In view of the risks related to hypoxemia and its high prevalence in endoscopic procedures (28-50%) we recommend that a routine oxygen supplementation policy be considered in every patient undergoing endoscopy, especially when additional procedures are to be performed.

Entities:  

Mesh:

Year:  1996        PMID: 8865828

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


  3 in total

1.  A randomized controlled trial comparing gastro-laryngeal tube with endotracheal intubation for airway management in patients undergoing ERCP under general anaesthesia.

Authors:  Deepak K Sreevastava; R N Verma; Ravi Verma
Journal:  Med J Armed Forces India       Date:  2018-03-05

2.  Difficult Airway Society guidelines for awake tracheal intubation (ATI) in adults.

Authors:  I Ahmad; K El-Boghdadly; R Bhagrath; I Hodzovic; A F McNarry; F Mir; E P O'Sullivan; A Patel; M Stacey; D Vaughan
Journal:  Anaesthesia       Date:  2019-11-14       Impact factor: 6.955

3.  Comparison of two supplemental oxygen methods during gastroscopy with propofol mono-sedation in patients with a normal body mass index.

Authors:  Liu-Jia-Zi Shao; Yi Zou; Fu-Kun Liu; Lei Wan; Shao-Hua Liu; Fang-Xiao Hong; Fu-Shan Xue
Journal:  World J Gastroenterol       Date:  2020-11-21       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.